- Home
- ARDX vs BMEZ Comparison
ARDX vs BMEZ Comparison
Compare ARDX & BMEZ Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- ARDX
- BMEZ
- Stock Information
- Founded
- ARDX 2007
- BMEZ N/A
- Country
- ARDX United States
- BMEZ United States
- Employees
- ARDX N/A
- BMEZ N/A
- Industry
- ARDX Biotechnology: Pharmaceutical Preparations
- BMEZ Trusts Except Educational Religious and Charitable
- Sector
- ARDX Health Care
- BMEZ Finance
- Exchange
- ARDX Nasdaq
- BMEZ Nasdaq
- Market Cap
- ARDX 882.9M
- BMEZ 923.8M
- IPO Year
- ARDX 2014
- BMEZ N/A
- Fundamental
- Price
- ARDX $5.57
- BMEZ $14.63
- Analyst Decision
- ARDX Strong Buy
- BMEZ
- Analyst Count
- ARDX 10
- BMEZ 0
- Target Price
- ARDX $10.65
- BMEZ N/A
- AVG Volume (30 Days)
- ARDX 4.4M
- BMEZ 391.3K
- Earning Date
- ARDX 10-30-2025
- BMEZ 01-01-0001
- Dividend Yield
- ARDX N/A
- BMEZ 8.71%
- EPS Growth
- ARDX N/A
- BMEZ N/A
- EPS
- ARDX N/A
- BMEZ 0.54
- Revenue
- ARDX $398,234,000.00
- BMEZ N/A
- Revenue This Year
- ARDX $18.90
- BMEZ N/A
- Revenue Next Year
- ARDX $31.52
- BMEZ N/A
- P/E Ratio
- ARDX N/A
- BMEZ $30.17
- Revenue Growth
- ARDX 58.12
- BMEZ N/A
- 52 Week Low
- ARDX $3.21
- BMEZ $12.93
- 52 Week High
- ARDX $6.78
- BMEZ $16.95
- Technical
- Relative Strength Index (RSI)
- ARDX 52.45
- BMEZ 38.18
- Support Level
- ARDX $5.59
- BMEZ $14.69
- Resistance Level
- ARDX $6.73
- BMEZ $15.30
- Average True Range (ATR)
- ARDX 0.30
- BMEZ 0.18
- MACD
- ARDX 0.09
- BMEZ -0.08
- Stochastic Oscillator
- ARDX 35.44
- BMEZ 5.08
About ARDX Ardelyx Inc.
Ardelyx Inc is a biopharmaceutical company developing and commercialize, first-in-class medicines that meet unmet medical needs. It has developed a platform that enabled the discovery of new biological mechanisms and pathways to develop potent and efficacious therapies that minimize the side effects and drug-drug interactions frequently encountered with traditional, systemically absorbed medicines. It product Tenapanor, branded as IBSRELA, is used for the treatment of adults with IBS-C. Tenapanor, branded as XPHOZAH, is used to reduce serum phosphorus in adults with CKD on dialysis as add-on therapy in patients who have an inadequate response to phosphate binders or who are intolerant of any dose of phosphate binder therapy.
About BMEZ BlackRock Health Sciences Term Trust of Beneficial Interest
BlackRock Health Sciences Trust II is a closed-ended management investment company. The investment objective is to provide total return through a combination of current income and long-term capital appreciation. The Trust seeks to achieve its investment objective by investing, under normal market conditions, at least 80% of its total assets in equity securities of energy and natural resources companies and equity derivatives with exposure to the energy and natural resources industry.